DIABETIC HYPEROSMOLAR COMA side effect
What is DIABETIC HYPEROSMOLAR COMA ?Drugs associated with DIABETIC HYPEROSMOLAR COMA
BETAMETHASONE BYETTA CETUXIMAB FOSAMAX GANCICLOVIR INIPOMP JANUVIA LASILIX NOVOLIN PAROXETINE SEROQUEL TEMOZOLOMIDE ZETIADIABETIC HYPEROSMOLAR COMA : Betamethasone Side Effects Report #5674067-7
Physician from JAPAN reported BETAMETHASONE PHOSPHATE problem on Mar 13, 2008. Female patient, 87 years of age, weighting 83.78 lb, was diagnosed with glioblastoma multiforme and was treated with BETAMETHASONE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, hyperglycaemia, hypernatraemia, hypoalbuminaemia, malignant neoplasm progression, oral intake reduced, pneumonia, . BETAMETHASONE PHOSPHATE dosage: unknown. During the same period patient was treated with TEMODAL, GASTER D, PHENOBAL, KYTRIL, PARAPLATIN, OMEPRAL. Patient died on 03/19/2007.
DIABETIC HYPEROSMOLAR COMA : Zetia Side Effects Report #5596329-4
ZETIA problem was reported by a Physician from JAPAN on Jan 11, 2008. Male patient, 74 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, hyperglycaemia, hypernatraemia, pneumonia, renal failure acute, rhabdomyolysis, . ZETIA dosage: unknown. During the same period patient was treated with ACARBOSE, GLIMEPIRIDE, HALOPERIDOL, VALPROATE, ASPIRIN ALUMINUM, DONEPEZIL HYDROCHLORIDE, AMLODIPINE BESYLATE, GLYBURIDE. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Cetuximab Side Effects Report #5487217-2
Health Professional from GERMANY reported CETUXIMAB problem on Oct 08, 2007. Male patient, 59 years of age, was diagnosed with colorectal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . CETUXIMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/15/2007.
DIABETIC HYPEROSMOLAR COMA : Cetuximab Side Effects Report #5493548-2
CETUXIMAB problem was reported by a Health Professional from GERMANY on Oct 15, 2007. Male patient, 59 years of age, was diagnosed with colorectal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . CETUXIMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/15/2007.
DIABETIC HYPEROSMOLAR COMA : Cetuximab Side Effects Report #5499633-3
Physician from UNITED KINGDOM reported CETUXIMAB problem on Oct 23, 2007. Male patient, 59 years of age, was diagnosed with type 2 diabetes mellitus, colorectal cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . CETUXIMAB dosage: 400 MG/M2 LOADING DOSE FOLLOWED BY A WEEKLY INFUSION OF 250 MG/M2. During the same period patient was treated with METFORMIN, FLUOROURACIL, OXALIPLATIN, STEROID. Patient was hospitalized. Patient died on 03/15/2007.
DIABETIC HYPEROSMOLAR COMA : Januvia Side Effects Report #5464663-4
JANUVIA problem was reported by a Physician from UNITED STATES on Sept 14, 2007. Female patient, 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . JANUVIA dosage: unknown. During the same period patient was treated with INSULIN, METFORMIN. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Ganciclovir Side Effects Report #5419535-8
Physician from UNITED KINGDOM reported GANCICLOVIR problem on Aug 06, 2007. Male patient, 69 years of age, was diagnosed with glioma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . GANCICLOVIR dosage: unknown. During the same period patient was treated with CEREPRO, TEMOZOLOMIDE. Patient was hospitalized. Patient died on 04/11/2007.
DIABETIC HYPEROSMOLAR COMA : Ganciclovir Side Effects Report #5390247-2
GANCICLOVIR problem was reported by a Physician from UNITED KINGDOM on July 09, 2007. Male patient, 69 years of age, was diagnosed with glioma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . GANCICLOVIR dosage: unknown. During the same period patient was treated with CEREPRO. Patient was hospitalized. Patient died on 04/11/2007.
DIABETIC HYPEROSMOLAR COMA : Ganciclovir Side Effects Report #5390247-2
Physician from UNITED KINGDOM reported GANCICLOVIR problem on July 09, 2007. Male patient, 69 years of age, was diagnosed with glioma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: diabetic hyperosmolar coma, . GANCICLOVIR dosage: unknown. During the same period patient was treated with CEREPRO. Patient was hospitalized. Patient died on 04/11/2007.
DIABETIC HYPEROSMOLAR COMA : Novolin Side Effects Report #5669066-5
NOVOLIN N problem was reported by a Pharmacist from JAPAN on Mar 05, 2008. Female patient, 73 years of age, weighting 94.80 lb, was diagnosed with type 2 diabetes mellitus, cardiac failure chronic and was treated with NOVOLIN N. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, diabetic hyperosmolar coma, injection site induration, . NOVOLIN N dosage: unknown. During the same period patient was treated with NOVOLIN R, WARFARIN, LANIRAPID, NOIDOUBLE, DIART, SOLUTIONS PARENTERAL NUTRITION, SOLUTIONS PARENTERAL NUTRITION, SOLUTIONS PARENTERAL NUTRITION. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Betamethasone Side Effects Report #5545376-7
Physician from JAPAN reported BETAMETHASONE PHOSPHATE problem on Sept 21, 2007. Female patient, 87 years of age, weighting 83.78 lb, was diagnosed with glioblastoma multiforme and was treated with BETAMETHASONE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, diabetic hyperosmolar coma, hyperglycaemia, hypernatraemia, hypoalbuminaemia, neoplasm progression, oral intake reduced, pneumonia, white blood cell count increased, . BETAMETHASONE PHOSPHATE dosage: unknown. During the same period patient was treated with TEMODAL, FAMOTIDINE, PHENOBAL, KYTRIL, PARAPLATIN, OMEPRAL. Patient died on 03/19/2007.
DIABETIC HYPEROSMOLAR COMA : Fosamax Side Effects Report #5507099-X
FOSAMAX problem was reported by a Health Professional from FRANCE on Oct 30, 2007. Male patient, 80 years of age, was diagnosed with osteoporosis, pulmonary fibrosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, diabetic hyperosmolar coma, pancreatitis acute, respiratory failure, . FOSAMAX dosage: unknown. During the same period patient was treated with PREDNISONE, FUROSEMIDE, TIANEPTINE, AMLODIPINE BESYLATE, CALCIUM CITRATE AND CHOLECALCIFEROL. Patient was hospitalized. Patient died on 08/24/2007.
DIABETIC HYPEROSMOLAR COMA : Byetta Side Effects Report #5519501-8
Physician from INDIA reported BYETTA problem on Nov 02, 2007. Female patient, 65 years of age, weighting 229.3 lb, was diagnosed with diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: dehydration, diabetic hyperosmolar coma, vomiting, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Seroquel Side Effects Report #5473268-0
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Male patient was diagnosed with depression and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, diabetic hyperosmolar coma, . SEROQUEL dosage: unknown. Patient died on 12/28/2005.
DIABETIC HYPEROSMOLAR COMA : Temozolomide Side Effects Report #5469742-3
Consumer or non-health professional from UNITED STATES reported TEMOZOLOMIDE problem on Sept 26, 2007. Male patient, weighting 167.3 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetic hyperosmolar coma, . TEMOZOLOMIDE dosage: 1260 MG. During the same period patient was treated with DILANTIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Lasilix Side Effects Report #5423594-6
LASILIX problem was reported by a Consumer or non-health professional from on Aug 20, 2007. Female patient, 93 years of age, was diagnosed with osteoporosis and was treated with LASILIX. After drug was administered, patient experienced the following problems/side effects: aphasia, diabetic hyperosmolar coma, hyperglycaemia, . LASILIX dosage: unknown. During the same period patient was treated with CELECTOL, SERC, KARDEGIC, INIPOMP, PROTELOS, STILNOX. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Inipomp Side Effects Report #5425223-4
Health Professional from FRANCE reported INIPOMP problem on Aug 20, 2007. Female patient, 93 years of age, was diagnosed with osteoporosis, cardiac failure and was treated with INIPOMP. After drug was administered, patient experienced the following problems/side effects: aphasia, diabetic hyperosmolar coma, . INIPOMP dosage: unknown. During the same period patient was treated with KARDEGIC, PROTELOS, CELECTOL, LASIX, STILNOX. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Inipomp Side Effects Report #5447423-X
INIPOMP problem was reported by a Health Professional from FRANCE on Aug 29, 2007. Female patient, 93 years of age, was diagnosed with osteoporosis, cardiac failure and was treated with INIPOMP. After drug was administered, patient experienced the following problems/side effects: aphasia, blood calcium increased, diabetic hyperosmolar coma, type 1 diabetes mellitus, . INIPOMP dosage: unknown. During the same period patient was treated with STILNOX, STRONTIUM RANELATE, SERC, CELECTOL, KARDEGIC, LASIX. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Inipomp Side Effects Report #5447423-X
Health Professional from FRANCE reported INIPOMP problem on Aug 29, 2007. Female patient, 93 years of age, was diagnosed with osteoporosis, cardiac failure and was treated with INIPOMP. After drug was administered, patient experienced the following problems/side effects: aphasia, blood calcium increased, diabetic hyperosmolar coma, type 1 diabetes mellitus, . INIPOMP dosage: unknown. During the same period patient was treated with STILNOX, STRONTIUM RANELATE, SERC, CELECTOL, KARDEGIC, LASIX. Patient was hospitalized. Patient recovered.
DIABETIC HYPEROSMOLAR COMA : Paroxetine Side Effects Report #5402843-4
PAROXETINE problem was reported by a Consumer or non-health professional from ITALY on Aug 29, 2006. Male patient, 77 years of age, was diagnosed with psychotic disorder and was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, coagulopathy, diabetic hyperosmolar coma, disseminated intravascular coagulation, electroencephalogram abnormal, metabolic alkalosis, neuroleptic malignant syndrome, . PAROXETINE dosage: 20 MG (20 MG, 1 IN 1 D);. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient died.
DIABETIC HYPEROSMOLAR COMA : Paroxetine Side Effects Report #5402843-4
Consumer or non-health professional from ITALY reported PAROXETINE problem on Aug 29, 2006. Male patient, 77 years of age, was diagnosed with psychotic disorder and was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, coagulopathy, diabetic hyperosmolar coma, disseminated intravascular coagulation, electroencephalogram abnormal, metabolic alkalosis, neuroleptic malignant syndrome, . PAROXETINE dosage: 20 MG (20 MG, 1 IN 1 D);. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient died.